biotech.today

Details

  • ●Modalities: proteins, biologics
  • ●Therapeutic areas: Undisclosed
  • ●Key targets:
  • ●Indications: Undisclosed
  • ●Funding: $50M

Partners & investors

  • Radical Ventures· Investor
  • Sofinnova· Investor

Key considerations

  • ●$50M seed (2024)
  • ●Radical Ventures + Sofinnova backing
  • ●DeepMind alumni founding team
Get live updates on Latent Labs’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Simon Kohl

Co-Founder & CEO

ml-researchex-DeepMind
Visit website →LinkedIn →